Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.


Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Electronic address: [Email]


To investigate the impact of the risk group disagreement between the Memorial Sloan Kettering Cancer Center (MSKCC) and the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) models on prognosis.


C-reactive protein,Metastasis,Neutrophil,Renal cell carcinoma,Risk model,